Example: Heart Attack

Clinical Trials Sponsored by Getz Pharma

Total 9 results

NCT04665284

Completed

Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus

Conditions: Type II Diabetes Mellitus
NCT04664894

Completed

Direct Acting Anti-Viral's In Chronic HCV Patients

Conditions: Safety Issues
NCT04301219

Completed

Knowledge and Practices of ADR Reporting in LMICs

Conditions: Adverse Reaction
NCT02600780

Completed

Zurig (Febuxostat) 40mg Efficacy and Safety Trial

Conditions: Hyperuricemia
NCT03710057

Completed

Effect of Ivabradine in Lowering Heart Rate and Quality of Life in Chronic Heart Failure Patients

Conditions: Chronic Heart Failure
NCT02601976

Completed

Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population

Conditions: Hepatitis C
NCT01770483

Completed

The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients

Conditions: Hepatitis C, Chronic, DIABETES MELLITUS Type 2
NCT00415961

Terminated

Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety

Conditions: Coronary Disease
NCT00502970

Completed

Short Course of Interferon Treatment in Patients With HCV Infection

Conditions: Hepatitis C, Chronic Disease, Treatment